Patents by Inventor Lisa Dunkle

Lisa Dunkle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising a combination of CCR5 and CXCR4 antagonists
    Publication number: 20070123538
    Abstract: A composition including a CXCR4 antagonist and a CCR5 antagonist represented by formula I or II: or an acceptable salt, solvate or ester thereof. The CXCR4 antagonist includes at least one of AMD-070, CS-3955, KRH-1120, KRH-2731, and KRH-1636.
    Type: Application
    Filed: November 28, 2006
    Publication date: May 31, 2007
    Inventors: Lisa Dunkle, Julie Strizki, Bahige Baroudy, Jayaram Tagat
  • Method for synthesizing ?-L-5-fluoro-2?,3?-dideoxy-2?,3?-didehydrocytidine (?-L-FD4C)
    Patent number: 6897302
    Abstract: The invention provides a method of synthesizing ?-L-5-fluoro-2?,3?-dideoxy-2?,3?-didehydrocytidine (?-L-FD4C). The method allows for large-scale production of ?-L-FD4C in an efficient, cost-effective, and environmentally sound manner.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: May 24, 2005
    Assignee: Achillion Pharmaceuticals, Inc.
    Inventors: Bo Kowalczyk, Zhao Lei, Ralph M. Schure, Lisa Dunkle
  • Method for synthesizing beta-L-5-fluoro-2',3'-dideoxy-2',3'-didehydrocytidine (beta-L-FD4C)
    Publication number: 20040147479
    Abstract: The invention provides a method of synthesizing &bgr;-L-5-fluoro-2′,3′-dideoxy-2′,3′-didehydrocytidine (&bgr;-L-FD4C). The method allows for large-scale production of &bgr;-L-FD4C in an efficient, cost-effective, and environmentally sound manner.
    Type: Application
    Filed: April 11, 2003
    Publication date: July 29, 2004
    Applicant: Achillion Pharmaceuticals, Inc.
    Inventors: Bo Kowalczyk, Zhao Li, Ralph M. Schure, Lisa Dunkle